Generative AI (GenAI) Lab at Osaka University focuses on generative AI for science, specializing in AI-driven drug discovery and medical innovation. We aim to develop reliable, efficient, and interpretable AI solutions to advance biomedical and pharmaceutical research, ultimately improving human health. Our work explores cutting-edge applications of large language models (LLMs) and generative AI in medicine and drug development. Key areas include molecular generation, de novo drug design, scaffold-based functional group generation, biomedical data augmentation, and explainable AI for healthcare. By harnessing state-of-the-art AI, we strive to revolutionize therapeutic discovery and medical research with both scientific depth and real-world impact.
September 2nd, 2025 I was invited to give a talk at Huazhong Agricultural University, Wuhan.
August 30th, 2025 I was invited to give a talk at South China Normal University, Guangzhou.
August 1st, 2025 Our one paper has been accepted to the Machine Intelligence Research (IF: 8.7).
July 27, 2025 Invited to attend the World Artificial Intelligence Conference (WAIC) and delivered a speech as a guest speaker.
May 28, 2025 Our one paper has been accepted to the ECML-PKDD-25 main track (Acceptance rate: 24%).
April 30, 2025 Our one paper has been accepted to the IJCAI-25 main track (Acceptance rate: 19%).
February 27, 2025 I am seeking PhD and Master's students to join our team.
February 1st, 2025 I have been serving as an Associate Professor at Osaka University.